Daily practice use of bortezomib in relapsed/refractory multiple myeloma: Safety/efficacy results of a compassionate use program in Switzerland. (2007). Swiss Medical Weekly, 137(2122), 317-322. https://doi.org/10.4414/smw.2007.11716